Salmonella Cancer Therapy Metabolically Disrupts Tumours at the Collateral Cost of T Cell Immunity

Researchers used distal T cell receptor and IFNγ reporter mice and a colorectal cancer model to interrogate T cell activity during bacterial cancer therapy with attenuated Salmonella enterica Typhimurium.